DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Lip GY, Rasmussen LH, Olsson SB. , et al; Steering Committee.
Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a Phase II study of AZD0837 in patients who are appropriate for but unable or unwilling to take vitamin K antagonist therapy.
Thromb Res 2011;
127 (02) 91-99
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.